Peritoneal Mesothelioma
📧 Sign up to get email alerts when something new happens for Peritoneal Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy with or without immunotherapy for peritoneal mesothelioma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies [Phase 1]
This is a Phase 1 clinical trial evaluating individual responses to hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcino…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for IDE892 evaluating monotherapy and combination in MTAP-deleted advanced solid tumors. The study is currentl…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis [NA]
Ongoing recruitment for a study evaluating whether cardiac coherence can reduce anxiety in patients operated for peritoneal carcinomatosis (…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: PTC-Guided Therapy for Peritoneal Mesothelioma [NA]
This Clinical Trials update shows that a PTC-guided therapy trial for peritoneal mesothelioma is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers [Phase 2]
A national platform coordinating five Phase II academic trials at Lyon to assess the safety and efficacy of the domvanalimab + zimberelimab …
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
University of Chicago is recruiting for a tissue procurement study across multiple cancers in patients undergoing surgery or biopsy to colle…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma [Phase 2]
This clinical trial update describes an ongoing Phase 2 study evaluating additional chemotherapy after surgery for malignant peritoneal meso…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Pembrolizumab in Treating Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial evaluating pembrolizumab in malignant mesothelioma and related subtypes; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
The trial is recruiting patients who received hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal cancers, including peritoneal…
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: French National Registry of Rare Peritoneal Surface Malignancies
An update on the French National Registry of Rare Peritoneal Surface Malignancies (NCT02834169) detailing conditions affecting peritoneal su…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays
Clinical trial update describing genomic analysis of peritoneal mesothelioma using comparative genomic hybridization (CGH) arrays; study sta…
-
CLINICAL_TRIALS research · 2015-10-27Clinical Trial Update: A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) [Phase 2]
Phase 2 clinical trial update on Tremelimumab combined with the anti-PD-L1 antibody durvalumab (MEDI4736) for malignant mesothelioma, includ…